Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / SHS USD
-
Total 13F shares
-
56,183,461
-
Share change
-
+2,483,329
-
Total reported value
-
$9,670,926,964
-
Put/Call ratio
-
42%
-
Price per share
-
$172.30
-
Number of holders
-
373
-
Value change
-
+$435,954,554
-
Number of buys
-
209
-
Number of sells
-
135
Institutional Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q2 2018
As of 30 Jun 2018,
Jazz Pharmaceuticals plc - SHS USD (JAZZ) was held by
373 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
56,183,461 shares.
The largest 10 holders included
FMR LLC, PUTNAM INVESTMENTS LLC, VANGUARD GROUP INC, BlackRock Inc., JPMORGAN CHASE & CO, Bank of New York Mellon Corp, TIAA CREF INVESTMENT MANAGEMENT LLC, Partner Fund Management, L.P., STATE STREET CORP, and Boston Partners.
This page lists
374
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.